Meeting Overview - The first meeting of the employee stock ownership plan for the R&D and production system of Tonghua Dongbao Pharmaceutical Co., Ltd. was held on January 7, 2026, via communication methods, with 121 participants representing a total of 27,964,300 shares, accounting for 100% of the plan's total shares [2][3] Resolutions Passed - The meeting approved the establishment of a management committee for the employee stock ownership plan to enhance management efficiency and protect the rights of plan holders [2][4] - The committee will consist of three members, with one serving as the chairperson, and its term will align with the duration of the employee stock ownership plan [2][4] Authorization of Management Committee - The meeting authorized the management committee to handle various matters related to the employee stock ownership plan, including convening meetings, managing accounts, and overseeing daily operations [5][6][7] - The committee is also empowered to make decisions regarding the plan's modifications, term extensions, and other significant matters [6][7] Share Pledge and Release Announcement - Tonghua Dongbao's controlling shareholder, Dongbao Industrial Group Co., Ltd., holds 641,362,975 shares, representing 32.75% of the total shares, with a cumulative pledge of 562,439,472 shares, accounting for 87.69% of their holdings and 28.72% of the total shares [9][10] - On January 6, 2026, Dongbao Group released a pledge of 42,000,000 shares and subsequently pledged an additional 22,000,000 shares, resulting in a total pledge of 562,439,472 shares [10][12] Financial Health and Risk Assessment - Dongbao Group's future financial obligations include 98,000,000 shares maturing in the next six months and 170,850,000 shares maturing within a year, with expected repayment sources from operating income and other revenues [12][20] - The group has a high debt-to-asset ratio and lower liquidity ratios, indicating potential financial pressure, but anticipates improved cash flow as ongoing projects reach maturity [20]
通化东宝药业股份有限公司关于 研发生产系统员工持股计划第一次 持有人会议决议的公告